Work

Reply

Year: 2013
Type: letter
Abstract: We thank Hakim and Grahame for their contribution to the debate on JH and CWP. As mentioned, the primary aim of our study was to establish the population prevalence of JH within an unselected general population–based sample using the 5-point JH questionnaire. The secondary aim was to determine whether the presence of JH was associated with pain reporting. Our data clearly showed a modest association between JH and disabling CWP. In their letter, Hakim and Grahame suggest that, anecdotally, the response to treatment in those with CWP is moderated by JH, or at least that health care professionals use this information to guide treatment decision making. To the best of our knowledge, there is no randomized controlled trial evidence to support this hypothesis. Moreover, the modest association between JH and disabling CWP shown in our study does not support further interpretation beyond that made in the article. Indeed, while this is an interesting question, it would have been speculative for us to discuss this in the published article. We thank Hakim and Grahame for highlighting the population prevalence of combined JH and CWP (3.4%). However, we question whether this represents a subpopulation of individuals with JHS because there were insufficient data within our study to support this statement. Finally, the Managing Unexplained Symptoms (CWP) in Primary Care: Involving Traditional and Accessible New Approaches trial did not collect the necessary data to inform debate about the issues that Hakim and Grahame raise.
Language: English
Open Access status: hybrid
Estimated APC paid: $4,640
OpenAlex ID: W4235767576
Cites:
Cited by:
Related to: 10